SWM
ONC

SHP Wealth Management’s BeOne Medicines Ltd ONC Stock Holding History

SHP Wealth Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Hold
42
– – ﹤0.01% 909
2026
Q1 		$12.5K Buy
42
+2
+5% +$647 ﹤0.01% 844
2025
Q4 		$12.2K Buy
+40
New +$13.1K ﹤0.01% 784

Other funds holding ONC

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return

SHP Wealth Management's ONC Position: Q2 2026 in Review

SHP Wealth Management held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 42 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #909.

SHP Wealth Management first reported a position in ONC in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.5K in Q1 2026. 135 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • SHP Wealth Management held 42 shares of BeOne Medicines Ltd worth $12K as of Q2 2026.
  • SHP Wealth Management left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #909 holding.
  • SHP Wealth Management first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 3 quarters since.
  • SHP Wealth Management's BeOne Medicines Ltd position peaked at $12.5K in Q1 2026.
  • 135 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.